Body composition as predictor of toxicity and outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) receiving nivolumab (Nivo).

被引：0
|
作者：
Shachar, Shlomit Strulov
Fried, Rachel
Shafran, Itamar
Moskovitz, Mor Tal
Williams, Grant Richard
Bar-Sela, Gil
Reiner-Benaim, Anat Strulov
Wollner, Mira
机构：
[1] Rambam Hlth Care Campus, Haifa, Israel
[2] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[3] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[4] Rambam Hlth Care Campus, Harduf, Israel
[5] Rambam Hlth Care Campus, Div Oncol, Haifa, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21010
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) with brain metastases treated with pembrolizumab-based therapy.
    Sun, Lova
    Davis, Christiana
    Marmarelis, Melina Elpi
    Jeffries, Seth
    Sulyok, Lydia Frenzel
    Hwang, Wei-Ting
    Singh, Aditi Puri
    Berman, Abigail T.
    Feigenberg, Steven J.
    Levin, William C.
    Bauml, Joshua
    Ciunci, Christine Agnes
    Cohen, Roger B.
    Langer, Corey J.
    Aggarwal, Charu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] CT texture analysis as a predictor of effectiveness of second line nivolumab in metastatic non-small cell lung cancer
    Ladwa, R.
    Roberts, K.
    Maggacis, N.
    O'Byrne, K.
    Miles, K.
    LUNG CANCER, 2019, 127 : S16 - S17
  • [23] Blood Cell Count Ratios at Diagnosis as Prognostic Markers in Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC)
    Ricardo, Eliza
    Boneti, Bianca
    Ribeiro, Taynan
    De Moraes, Rafael
    Freitas, Helano
    Da Costa, Alexandre
    Andrade, Victor
    De Lime, Vladmir Cordeiro
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S970 - S971
  • [24] Real-world treatment outcomes with brigatinib in patients with pretreated ALK plus metastatic non-small cell lung cancer (mNSCLC)
    Popat, S.
    Brustugun, T.
    Cadranel, J.
    Felip, E.
    Garassino, M. C.
    Griesinger, F.
    Helland, A.
    Hochmair, M. J.
    Perol, M.
    Bent-Ennakhil, N.
    Kruhl, C.
    Novello, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S866 - S866
  • [25] Influence of antibiotic therapy (ATB) on oncological outcomes of metastatic non-small cell lung cancer (mNSCLC) patients treated with chemoimmunotherapy (CIT).
    Clark, James
    Ricciuti, Biagio
    Bolina, Anita
    Venkatraman, Deepti
    Newsom-Davis, Thomas
    Ottaviani, Diego
    Lee, Karla
    Awad, Mark M.
    Pinato, David James
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer
    Sabatier, Renaud
    Nicolas, Emanuel
    Paciencia, Maria
    Jonville-Bera, Annie-Pierre
    Madroszyk, Anne
    Cecile, Maud
    Braticevic, Cecile
    Duran, Segolene
    Tassy, Louis
    Rouby, Franck
    Micallef, Joelle
    Rousseau, Frederique
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (05) : 494 - 500
  • [27] Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Elderly Patients: Survival Analysis Based on Platinum Retreatment
    Linsalmeida, T.
    Fernandes, R.
    Faccio, A.
    Reis Filho, P.
    Oliveira, H.
    Tavares, F.
    Peria, F.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S310 - S310
  • [28] The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer
    Tanvetyanon, Tawee
    Creelan, Benjamin C.
    Antonia, Scott J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 903 - 910
  • [29] Hyper-progressive disease in patients with advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo)
    Costantini, Adrien
    Corny, Jennifer
    Fallet, Vincent
    Renet, Sophie
    Friard, Sylvie
    Chouaid, Christos
    Duchemann, Boris
    Giroux-Leprieur, Etienne
    Taillade, Laurent
    Doucet, Ludovic
    Nguenang, Marina
    Jouveshomme, Stephane
    Wislez, Marie
    Tredaniel, Jean
    Cadranel, Jacques
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [30] Nivolumab (nivo) resumption in patients with advanced or metastatic non-small cell lung cancer (aNSCLC): Survival outcomes based on France and Germany real-world data (RWD)
    Perol, M.
    Sebastian, M.
    Barlesi, F.
    Schumann, C.
    Reynaud, D.
    Waldenberger, D.
    Lee, A.
    Varol, N.
    Penrod, J. R.
    Brellier, F.
    ANNALS OF ONCOLOGY, 2023, 34
12345